XML 21 R4.htm IDEA: XBRL DOCUMENT v3.21.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
TOTAL REVENUE $ 62,898 $ 54,693 $ 34,240
COST OF GOODS SOLD (10,873) (10,895) (9,302)
RESEARCH AND DEVELOPMENT EXPENSES, NET [1] (38,167) (44,616) (33,330)
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES (11,148) (9,899) (10,916)
OPERATING INCOME (LOSS) 2,710 (10,717) (19,308)
FINANCIAL EXPENSES (9,671) (7,966) (7,685)
FINANCIAL INCOME 438 407 536
FINANCIAL EXPENSES - NET (9,233) (7,559) (7,149)
NET LOSS FOR THE YEAR $ (6,523) $ (18,276) $ (26,457)
NET LOSS PER SHARE OF COMMON STOCK-BASIC AND DILUTED $ (0.22) $ (1.23) $ (1.80)
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING LOSS PER SHARE - BASIC AND DILUTED 29,148,047 14,838,213 14,713,518
Goods [Member]      
TOTAL REVENUE $ 16,236 $ 15,866 $ 8,978
License and R&D Services [Member]      
TOTAL REVENUE $ 46,662 $ 38,827 $ 25,262
[1] Includes deductible grants